Status:
RECRUITING
The Cohort for Patient-reported Outcomes, Imaging and Trial Inclusion in Metastatic BRAin Disease (COIMBRA)
Lead Sponsor:
UMC Utrecht
Conditions:
Brain Metastases, Adult
Brain Neoplasms, Adult, Malignant
Eligibility:
All Genders
18+ years
Brief Summary
The incidence of brain metastases is expected to increase because of better treatments of primary tumours. Novel diagnostic and therapeutic techniques are continuously being developed, all of which ne...
Detailed Description
The COIMBRA cohort is a prospective cohort, which will serve as a facility for efficient, systematic and simultaneous evaluation of new interventions and MRI sequences and prospective outcome studies ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years;
- Either radiographic and/or histologic proof of metastatic brain disease, or eligible for prophylactic cranial irradiation;
- Referred to the Department of Radiotherapy for cranial irradiation.
Exclusion
- Mental disorder or cognitive dysfunction that hinder the patient's ability to understand the informed consent procedure and/or study details;
- Patients with severe psychiatric disorders;
- Inability to understand the Dutch language.
Key Trial Info
Start Date :
April 26 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05267158
Start Date
April 26 2019
End Date
May 1 2026
Last Update
September 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Utrecht
Utrecht, Netherlands, 3508GA